AAAAAA

   
Results: 1-23 |
Results: 23
The influence of hormones on CD44 expression in endometrial and breast carcinomas
Authors: Durst, B Sorg, RV Roder, G Betz, B Beckmann, MW Niederacher, D Bender, HG Dall, P
Citation: B. Durst et al., The influence of hormones on CD44 expression in endometrial and breast carcinomas, ONCOL REP, 8(5), 2001, pp. 987-993
Clonal culture of fetal cells from maternal blood - Reply
Authors: Tutschek, B Reinhard, J Kogler, G Wernet, P Niederacher, D
Citation: B. Tutschek et al., Clonal culture of fetal cells from maternal blood - Reply, LANCET, 357(9260), 2001, pp. 962-962
Resistance to CD95-mediated apoptosis in breast cancer is not due to somatic mutation of the CD95 gene
Authors: Muschen, M Re, D Betz, B Moers, C Wolf, J Niederacher, D Diehl, V Beckmann, MW
Citation: M. Muschen et al., Resistance to CD95-mediated apoptosis in breast cancer is not due to somatic mutation of the CD95 gene, INT J CANC, 92(2), 2001, pp. 309-310
Hormones and hormone antagonists: Mechanisms of action in carcinogenesis of endometrial and breast cancer
Authors: Flototto, T Djahansouzi, S Glaser, M Hanstein, B Niederacher, D Brumm, C Beckmann, MW
Citation: T. Flototto et al., Hormones and hormone antagonists: Mechanisms of action in carcinogenesis of endometrial and breast cancer, HORMONE MET, 33(8), 2001, pp. 451-457
Gene amplification and expression of the steroid receptor coactivator SRC3(AIB1) in sporadic breast and endometrial carcinomas
Authors: Glaeser, M Floetotto, T Hanstein, B Beckmann, MW Niederacher, D
Citation: M. Glaeser et al., Gene amplification and expression of the steroid receptor coactivator SRC3(AIB1) in sporadic breast and endometrial carcinomas, HORMONE MET, 33(3), 2001, pp. 121-126
Inflammation of the myocardium as a trigger for arrhythmias
Authors: Klein, RM Vester, EG Brehm, MU Dees, H Picard, F Niederacher, D Beckmann, MW Strauer, BE
Citation: Rm. Klein et al., Inflammation of the myocardium as a trigger for arrhythmias, Z KARDIOL, 89, 2000, pp. 24-35
Clonal culture of fetal cells from maternal blood
Authors: Tutschek, B Reinhard, J Kogler, G Wernet, P Niederacher, D
Citation: B. Tutschek et al., Clonal culture of fetal cells from maternal blood, LANCET, 356(9243), 2000, pp. 1736-1737
Inherited cancer syndromes in gynaecology: what the practitioner needs to know!
Authors: Kuschel, B Kochli, OR Niederacher, D Muller, H Beckmann, MW
Citation: B. Kuschel et al., Inherited cancer syndromes in gynaecology: what the practitioner needs to know!, SCHW MED WO, 130(10), 2000, pp. 362-375
DNA methylation and the mechanisms of CDKN2A inactivation in transitional cell carcinoma of the urinary bladder
Authors: Florl, AR Franke, KH Niederacher, D Gerharz, CD Seifert, HH Schulz, WA
Citation: Ar. Florl et al., DNA methylation and the mechanisms of CDKN2A inactivation in transitional cell carcinoma of the urinary bladder, LAB INV, 80(10), 2000, pp. 1513-1522
CD95 ligand expression as a mechanism of immune escape in breast cancer
Authors: Muschen, M Moers, C Warskulat, U Even, J Niederacher, D Beckmann, MW
Citation: M. Muschen et al., CD95 ligand expression as a mechanism of immune escape in breast cancer, IMMUNOLOGY, 99(1), 2000, pp. 69-77
Mechanisms of ovarian steroid hormones and antioestrogens in the development of carcinomas of the breast and endometrium
Authors: Beckmann, MW Hanstein, B Niederacher, D Jap, D Kuschel, B Bender, HG
Citation: Mw. Beckmann et al., Mechanisms of ovarian steroid hormones and antioestrogens in the development of carcinomas of the breast and endometrium, GEBURTSH FR, 60(2), 2000, pp. 71-76
The exon 13 duplication in the BRCA1 gene is a founder mutation present ingeographically diverse populations
Authors: Mazoyer, S Leary, J Kirk, J Fleischmann, E Wagner, T Claes, K Messiaen, L Foulkes, W Desrochers, M Simard, J Phelan, CM Kwan, E Narod, SA Vahteristo, P Nevanlinna, H Durando, X Bignon, YJ Peyrat, JP Bonnardel, C Sinilnikova, OM Puget, N Lenoir, GM Mazoyer, S Audoynaud, C Goldgar, D Maugard, C Caux, V Gad, S Stoppa-Lyonnet, D Nogues, C Lidereau, R Machavoine, C Bressac-de Paillerets, B Kuschel, B Betz, B Niederacher, D Beckmann, MW Hamann, U Gayther, SA Ponder, BAP Robinson, M Taylor, GR Bishop, T Catteau, A Solomon, E Cohen, B Steel, M Collins, N Stratton, M van der Looij, M Olah, E Miller, NJ Barton, DE Sverdlov, RS Friedman, E Radice, P Montagna, M Sensi, E Caligo, M van Eijk, R Devilee, P van der Luijt, R Heimdal, K Moller, P Borg, A Diez, O Cortes, J Domenech, M Baiget, M Osorio, A Benitez, J Borg, A Maillet, P Sappino, AP Ozdag, H Ozcelik, T Ozturk, M Rohlfs, EM Boyd, J McDermott, D Offit, K Unger, M Nathanson, K Weber, BL Sellers, TA Hampton, E Couch, FJ Neuhausen, S
Citation: S. Mazoyer et al., The exon 13 duplication in the BRCA1 gene is a founder mutation present ingeographically diverse populations, AM J HU GEN, 67(1), 2000, pp. 207-212
Loss of heterozygosity at 11q23.1 and survival in breast cancer: Results of a large European study
Authors: Laake, K Launonen, V Niederacher, D Gudlaugsdottir, S Seitz, S Rio, P Champeme, MH Bieche, I Birnbaum, D White, G Sztan, M Sever, N Plummer, S Osorio, A Broeks, A Huusko, P Spurr, N Borg, A Cleton-Jansen, AM van't Veer, L Benitez, J Casey, G Peterlin, B Olah, E Varley, J Bignon, YJ Scherneck, S Sigurdardottir, V Lidereau, R Eyfjord, J Beckmann, MW Winqvist, R Skovlund, E Borresen-Dale, AL
Citation: K. Laake et al., Loss of heterozygosity at 11q23.1 and survival in breast cancer: Results of a large European study, GENE CHROM, 25(3), 1999, pp. 212-221
H-ras gene amplification or mutation is not common in human primary breastcancer
Authors: Schondorf, T Andrack, A Niederacher, D Scharl, A Becker, M Engel, H Gohring, UJ
Citation: T. Schondorf et al., H-ras gene amplification or mutation is not common in human primary breastcancer, ONCOL REP, 6(5), 1999, pp. 1029-1033
Genetic analysis of CDKN2A gene inactivation in sporadic ovarian cancer
Authors: Yan, HY An, HX Beckmann, MW Bender, HG Niederacher, D
Citation: Hy. Yan et al., Genetic analysis of CDKN2A gene inactivation in sporadic ovarian cancer, CHIN MED J, 112(10), 1999, pp. 946-946
Mutations and amplification of oncogenes in endometrial cancer
Authors: Niederacher, D An, HX Cho, YJ Hantschmann, P Bender, HG Beckmann, MW
Citation: D. Niederacher et al., Mutations and amplification of oncogenes in endometrial cancer, ONCOL-BASEL, 56(1), 1999, pp. 59-65
CD95 ligand expression in dedifferentiated breast cancer
Authors: Muschen, M Moers, C Warskulat, U Niederacher, D Betz, B Even, J Lim, A Josien, R Beckmann, MW Haussinger, D
Citation: M. Muschen et al., CD95 ligand expression in dedifferentiated breast cancer, J PATHOLOGY, 189(3), 1999, pp. 378-386
Regulation of CD95 (Apo-1/Fas) ligand and receptor expression in squamous-cell carcinoma by interferon-gamma and cisplatin
Authors: Moers, C Warskulat, U Muschen, M Even, J Niederacher, D Josien, R Koldovsky, U Beckmann, MW Haussinger, D
Citation: C. Moers et al., Regulation of CD95 (Apo-1/Fas) ligand and receptor expression in squamous-cell carcinoma by interferon-gamma and cisplatin, INT J CANC, 80(4), 1999, pp. 564-572
European multicenter study on LOH of APOC3 at 11q23 in 766 breast cancer patients: relation to clinical variables
Authors: Launonen, V Laake, K Huusko, P Niederacher, D Beckmann, MW Barkardottir, RB Geirsdottir, EK Gudmundsson, J Rio, P Bignon, YJ Seitz, S Scherneck, S Bieche, I Champeme, MH Birnbaum, D White, G Varley, J Sztan, M Olah, E Osorio, A Benitez, J Spurr, N Velikonja, N Peterlin, B Borg, A Cleton-Jansen, AM Devilee, P Bloigu, R Lidereau, R Borresen-Dale, AL Winqvist, R
Citation: V. Launonen et al., European multicenter study on LOH of APOC3 at 11q23 in 766 breast cancer patients: relation to clinical variables, BR J CANC, 80(5-6), 1999, pp. 879-882
CDKN2A gene inactivation in epithelial sporadic ovarian cancer
Authors: Niederacher, D Yan, HY An, HX Bender, HG Beckmann, MW
Citation: D. Niederacher et al., CDKN2A gene inactivation in epithelial sporadic ovarian cancer, BR J CANC, 80(12), 1999, pp. 1920-1926
Gene amplification and overexpression of CDK4 in sporadic breast carcinomas is associated with high tumor cell proliferation
Authors: An, HX Beckmann, MW Reifenberger, G Bender, HG Niederacher, D
Citation: Hx. An et al., Gene amplification and overexpression of CDK4 in sporadic breast carcinomas is associated with high tumor cell proliferation, AM J PATH, 154(1), 1999, pp. 113-118
Reliability and clinical application of fetal RhD genotyping with two different fluorescent duplex polymerase chain reaction assays: Three years' experience
Authors: Crombach, G Niederacher, D Larbig, D Picard, F Tutschek, B Beckmann, MW Bender, HG
Citation: G. Crombach et al., Reliability and clinical application of fetal RhD genotyping with two different fluorescent duplex polymerase chain reaction assays: Three years' experience, AM J OBST G, 180(2), 1999, pp. 435-440
Molecular and cytogenetic techniques in oncology
Authors: Niederacher, D Kiechle, M Arnold, N
Citation: D. Niederacher et al., Molecular and cytogenetic techniques in oncology, GYNAKOLOGE, 31(12), 1998, pp. 1019-1032
Risultati: 1-23 |